Wassim Abida
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Cancer Research top 5%
- Immunology
- Co-authors
- Wei GuHoward I. ScherNikolaus SchultzCharles L. SawyersWenhui ZhaoAnatoly NikolaevWenzhu ZhangMichael J. Morris
- Topics
- Prostate Cancer Treatment and Research (63 papers)PARP inhibition in cancer therapy (33 papers)Cancer Genomics and Diagnostics (20 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Wassim Abida
85 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.0k
- Pulmonary and Respiratory Medicine 945
- Oncology 785
- Cancer Research 583
- Immunology 138
Countries citing papers authored by Wassim Abida
This map shows the geographic impact of Wassim Abida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wassim Abida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wassim Abida more than expected).
Fields of papers citing papers by Wassim Abida
This network shows the impact of papers produced by Wassim Abida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wassim Abida. The network helps show where Wassim Abida may publish in the future.
Co-authorship network of co-authors of Wassim Abida
This figure shows the co-authorship network connecting the top 25 collaborators of Wassim Abida. A scholar is included among the top collaborators of Wassim Abida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wassim Abida. Wassim Abida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | Guidelines for Management of Treatment-Emergent Adverse Events During Rucaparib Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer | 4 |
| 7 | 26 | |
| 8 | 3 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 119 | |
| 12 | 17 | |
| 13 | 97 | |
| 14 | 170 | |
| 15 | 2 | |
| 16 | 10 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 86 | |
| 20 | 162 |
About Wassim Abida
Wassim Abida is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (63 papers), PARP inhibition in cancer therapy (33 papers) and Cancer Genomics and Diagnostics (20 papers). The work is most often cited by research in Cancer Research (583 citations), Pulmonary and Respiratory Medicine (945 citations) and Oncology (785 citations). Wassim Abida has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Wei Gu, Howard I. Scher, Nikolaus Schultz, Charles L. Sawyers, Wenhui Zhao, Anatoly Nikolaev, Wenzhu Zhang, Michael J. Morris, Hening Lin and Virginia W. Cornish. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.